Document Type : Clinical Notes
Authors
- Aviraj Satish Deshmukh 1
- Ravinder Jeet Singh 1
- Stuart McGregor 1
- Stefano Maria Priola 2
- Ruba Nabil Mahmoud Kiwan 3
1 Division of Clinical Sciences, Health Sciences North, Northern Ontario School of Medicine, Sudbury, Ontario, Canada
2 Division of Neurosurgery, Health Sciences North, Northern Ontario School of Medicine, Sudbury, Ontario, Canada
3 Health Sciences North, Northern Ontario School of Medicine, Sudbury, Ontario, Canada
Abstract
-
Keywords
- Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361(12): 1139-51.
- Aguilar MI, Hart RG, Kase CS, Freeman WD, Hoeben BJ, Garcia RC, et al. Treatment of warfarin-associated intracerebral hemorrhage: Literature review and expert opinion. Mayo Clin Proc 2007; 82(1): 82-92.
- Hankey GJ, Stevens SR, Piccini JP, Lokhnygina Y, Mahaffey KW, Halperin JL, et al. Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation. Stroke 2014; 45(5): 1304-12.
- Zhu W, He W, Guo L, Wang X, Hong K. The HAS-BLED Score for predicting major bleeding risk in anticoagulated patients with atrial fibrillation: A systematic review and meta-analysis. Clin Cardiol 2015; 38(9): 555-61.
- BasNS, Tufan A. Chronic subdural hematoma as a complication of medicinal leech therapy. Neurology Asia 2021; 26(3): 599-602.
- Kose A, Zengin S, Kose B, Gunay N, Yildirim C, Kilinc H, et al. Leech bites: Massive bleeding, coagulation profile disorders, and severe anemia. Am J Emerg Med 2008; 26(9): 1067-6.
- Conley K, Jamal Z, Juergens AL. Leech Bite. 2024.
- Poli D, Antonucci E, Vignini E, Martinese L, Testa S, Simioni P, et al. Anticoagulation resumption after intracranial hemorrhage in patients treated with VKA and DOACs. Eur J Intern Med 2020; 80: 73-7.
)